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International Ophthalmology is devoting a two num-
ber issue to Vogt–Koyanagi–Harada (VKH) disease.
The incentive for such an issue came from the 4th
Workshop and Symposium on VKH disease, held
May 23rd to 25, 2005 at the Hotel Fairmont in Monte
Carlo, Monaco (Picture 1). This workshop was a
follow-up on workshops held in Rome, Italy (2003)
and in Chiba, Japan (2001) (Picture 2) after the initial
workshop that was held in 1999 at Lake Arrowhead,
California. The initiative of this whole process has
to be put to the credit of Professor Narsing A. Rao
(USC, Los Angeles, USA) and Professor Masahiko
Usui (Tokyo Medical Colloge, Tokyo, Japan)
who decided to gather uveitis specialists worldwide
to start a reflection group that would address all
aspects of this disease first described in 1906 by the
Swiss ophthalmologist Alfred Vogt and then com-
prehensively analyzed by two Japanese ophthalmol-
ogists, Yoshizo Koyanagi and Einosuke Harada.
In Monaco, where a very rich program was put
together containing many interesting and even out-
standing presentations, it was felt that a publication
on VKH disease was very much desirable to include
some of the recent developments on the topic. In
the following year the baselines for this publication
were set and by the end of 2006 a great number of
manuscripts had been submitted, resulting in the
present issue.
Twenty-one contributions were accepted after
peer-review, including one historical article, one
contribution to ‘‘Perspectives and Expert Opinion’’,
one Review on histopathology, one original article on
immunopathogenicity of VKH in the ‘‘Laboratory
Sciences’’ section, five original epidemiologic arti-
cles on areas where little epidemiologic data were
available so far, three original clinical articles on
imaging in VKH, six other original articles on clinical
aspects as well as two case reports.
Herbort and Mochizuki, in their article on the
history of the disease, gave not only a very detailed
account on the circumstances and the authors that
described the disease first and defined its clinical
boundaries but also on the historical background of
ophthalmology in Switzerland and Japan at this
epoch. The review article by Rao on the histopathol-
ogy in VKH sets the stage and explains the pathology
of VKH. It indicates that the disease is a primary
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choroidal stromal inflammatory disease directed
against choroidal pigment, charcterized by inflam-
matory foci in the choroidal stroma that involves the
choriocapillaris only later in subacute or chronic
disease. In ‘‘Perspectives and Expert Opinions’’,
experts from Japan, the Middle-East and USA are
giving their expert opinion on the diagnostic work-
up, investigational tests and management of a case of
VKH disease. Experts mostly agreed among each
others with slight differences on the importance of
lumbar puncture and the use of more precise and
modern investigational methods of the choroidal
space such as indocyanine green angiography (ICGA)
that was deemed helpful especially in atypical cases
by two of the experts.
In the section of ‘‘laboratory sciences’’, Sugita and
colleagues contributed a fine piece of work exploring
the immunopathology of the disease and the possi-
bility of cytomegalovirus triggering cross reacting of
T lymphocytes against tyrosinase. Ohno and co-
workers showed that cerebrospinal fluid T lympho-
cytes from VKH patients were found to show similar
profiles of surface markers than lymphcyes from the
aqueous humor, differing from blood lymphocytes
and showing that the same immonological reaction
takes place in the eye and meninges.
In the section on epidemiological reports, five
articles are presenting the regional characeristics of
VKH in Northern Africa (Khairallah and colleagues
from Monastir, Tunisia), in Turkey (Tugal-Tutkun
and colleagues), in Southern India (Murthy and
colleagues from Hyderabad), in Singapore (Chee
and colleagues) and the hispanic population of
Southern California (Rao and colleagues).
In the section on imaging, Arellanes and co-
workers give a review on fluorescein angiographic
findings in VKH patients. Fardeau and colleagues
stress the importance of indocyanine green angiog-
raphy (ICGA), especially useful in VKH disease
where the heart of inflammation is situated within the
choroidal stroma. Herbort and colleagues put forward
the extreme sensitivity of ICGA to explore the
choroid, being especially useful in atypical or
subclinical disease. The authors stress the consistency
of ICGA signs making it a useful tool for monitoring
disease activity and to detect subclinical recurrences.
The value of cerebrospinal fluid (CSF) analysis is
viewed differently depending on the area of practice.
Mochizuki and colleagues stress the importance of
CSF analysis that allows to hasten the diagnosis and
contributes to early treatment, a factor known to be
important for the prognosis of the disease. In the
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USA, where medico-legal considerations are a major
concern, Rao and colleagues stress that the inherent
risks and complications associated with the procedure
must prompt the clinician to reserve this evaluation
for atypical cases.
A very detailed work presented by Abu El Asrar
and co-workers analysis outcome and prognostic
factors in VKH, giving information on many param-
eters. One imporant finding in their study showed that
long duration and slow tapering of corticosteroid
treatment was significantly associated with good
clinical outcome. Rao and colleagues analysed early
phase and late phase VKH patients, using the revised
diagnostic criteria for VKH disease. Finally, Bodaghi
and colleagues report a small series of cases with
refractory VKH disease treated with interferon alpha,
a treatment potentially beneficial for VKH disease.
In the meantime the 5th workshop on VKH disease
and sympathetic ophthalmia was organized in Tokyo
in the Akasaka Prince Hotel by Professors Usui and
Goto from the Tokyo Medical College from March
22 to 24th, 2007 It gathered uveitis specialists from
all over the world and confirmed the tendencies of the
2005 VKH workshop in Monaco. The importance of
prolonged corticosteroid therapy associated or not
with immunosuppressives was confirmed by studies
from different parts of the world and the sensitivity
and use of indocyanine green angiography for the
assessement and follow-up of VKH disease was
clearly shown to be essential in several presentations.
Further data on the Th1 autoimmune process against
melanin asociated proteins as well as on HLA
association of VKH were presented.
It was also decided during the 5th workshop to
pursue this cycle of workshops and to merge it with
other workshops on granulomatous disease such as
the International Workshop on Ocular Sarcoidosis
(IWOS) that has been held for the first time in Tokyo,
October 2006. The next meeting will be organized by
professor Soon Phaik Chee in February 2009 in
Singapore and the following meeting is scheduled in
2011 in Goa, India. During the 2007 Tokyo meeting,
Professor Usui was honored by Professor Rao as the
retiring chairman of the workshops and was named
honorary chairman (Picture 3). The whole process
will be carried on under the chairmanship of
Professor Rao.
Picture 3 Professor Narsing Rao hands Professor Usui a
certificate of appreciation for active work performed in the
field of VKH disease, naming Professor Usui Honorary
Chairman of the VKH Workshop cycle
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